Royal Trinity Hospice (RTH) has been an innovator and a leader in hospice care since 1891. It provides specialist palliative and end of life care to around 2500 patients each year from its state-of-the-art inpatient unit and throughout the community in seven London boroughs.
It is a vital part of the local healthcare system, caring for around half the people who die in this community each year. Its care is rated Outstanding by Care Quality Commission and it is free to use thanks to its retail and fundraising operations (the NHS funds under 30% of the cost).
In the three years before the pandemic, it grew its community patient numbers by around 25%, showing that its work has real impact across a very diverse demographic. Its team responded strongly to the challenges of Covid-19, remaining operational 24/7 for each patient who needed its services - a real tribute to the staff and donors who worked so hard to ensure that.
Today Trinity has a strong platform combining high quality care, strong stakeholder relationships with its Integrated Care Board partners, successful retail and fundraising operations, caring and expert staff, a great executive team, a supportive and engaged board and a stable financial position.
Trinity has a detailed plan to expand its services to reach 50% more people by 2030, because our community is living longer which means more demand and more complex care needs. 75% of us will need some sort of specialist palliative care at the end of life and the number of people who die with dementia and cancer will double by 2040 – so Trinity’s work will be even more vital than ever.
The hospice's strategic aim over the next couple of years is to expand its reach and impact while maintaining its high service quality and financial resilience, and to continue its position of leadership and innovation in the UK hospice sector